Kabi, Mylan and Neptune Thwarted In US Pemetrexed Proceedings
A US vitamin-regimen patent protecting Lilly’s Alimta pemetrexed brand until 2022 is valid, the US Court of Appeals has ruled.
A US vitamin-regimen patent protecting Lilly’s Alimta pemetrexed brand until 2022 is valid, the US Court of Appeals has ruled.